Skip to main content



Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

  • Sunday, Nov 10th
    8:00 AM – 8:15 AM MST
    ACoP Preconference - Exploring New Frontiers: Quantitative Pharmacology for Emerging Therapeutic Modalities - Welcome, Introduction & Problem Statement
    Location: Sonoran Sky Ballroom 4
    Co-Chair: Joy C. Hsu, PhD – Genentech
    Co-Chair: Mark Lovern, PhD (he/him/his) – InSilicoTrials
    Preconference
  • Sunday, Nov 10th
    8:15 AM – 9:00 AM MST
    A brief history of model-informed discovery and development of advanced therapies
    Location: Sonoran Sky Ballroom 4
    Speaker: Piet van der Graaf, PharmD, PhD – Certara
    Preconference
  • Sunday, Nov 10th
    9:00 AM – 10:15 AM MST
    Cell & Gene Therapies
    Location: Sonoran Sky Ballroom 4
    Moderator: Mark Lovern, PhD (he/him/his) – InSilicoTrials
    Speaker: Jared Weddell, PhD – Astellas
    Speaker: Hardik Mody, PhD (he/him/his) – Genentech
    Preconference
  • Sunday, Nov 10th
    9:00 AM – 9:25 AM MST
    Hitting the target (dose) in one shot: MIDD for cell and gene therapies
    Location: Sonoran Sky Ballroom 4
    Speaker: Jared Weddell, PhD – Astellas
    Preconference
  • Sunday, Nov 10th
    9:25 AM – 9:50 AM MST
    Quantitative Pharmacology Considerations in the Development of Cell Therapies - Opportunities & Challenges
    Location: Sonoran Sky Ballroom 4
    Speaker: Hardik Mody, PhD (he/him/his) – Genentech
    Preconference
  • Sunday, Nov 10th
    9:50 AM – 10:15 AM MST
    Quantitative Pharmacology Approach to Inform the Bench-to-Bed Translation of CRSPR-Based in-vivo Gene Editing Therapy across Multiple Development Phases
    Location: Sonoran Sky Ballroom 4
    Preconference
  • Sunday, Nov 10th
    10:30 AM – 11:45 AM MST
    siRNA Therapies
    Location: Sonoran Sky Ballroom 4
    Moderator: Nitin Mehrotra, Phd – Alnylam Pharmaceuticals
    Speaker: Jeff Kearns, PhD (he/him/his) – Novartis
    Speaker: Vivaswath S. Ayyar, PhD – J&J Innovative Medicine
    Speaker: Nitin Mehrotra, Phd – Alnylam Pharmaceuticals
    Preconference
  • Sunday, Nov 10th
    10:30 AM – 10:55 AM MST
    First, Best, or Next in class? Applying forward and reverse translation approaches to accelerate siRNA projects from discovery to FIH.
    Location: Sonoran Sky Ballroom 4
    Speaker: Jeff Kearns, PhD (he/him/his) – Novartis
    Preconference
  • Sunday, Nov 10th
    10:55 AM – 11:20 AM MST
    Quantitative Pharmacology Principles and Model-Informed Development Approaches for RNAi Therapeutics
    Location: Sonoran Sky Ballroom 4
    Speaker: Vivaswath S. Ayyar, PhD – J&J Innovative Medicine
    Preconference
  • Sunday, Nov 10th
    11:20 AM – 11:45 AM MST
    Innovating the landscape: Is MIDD of siRNA unique?
    Location: Sonoran Sky Ballroom 4
    Speaker: Nitin Mehrotra, Phd – Alnylam Pharmaceuticals
    Preconference
  • Sunday, Nov 10th
    12:45 PM – 1:45 PM MST
    The Regulatory Landscape of Quantitative Pharmacology for New Therapeutic Modalities at the FDA
    Location: Sonoran Sky Ballroom 4
    Moderator: Joy C. Hsu, PhD – Genentech
    Speaker: Sojeong Yi, PhD – FDA
    Panelist: Hao Zhu, PhD – ISoP
    Preconference
  • Sunday, Nov 10th
    1:45 PM – 3:00 PM MST
    Emerging New Therapeutic Modalities
    Location: Sonoran Sky Ballroom 4
    Moderator: Joy C. Hsu, PhD – Genentech
    Speaker: Donghua Yin, PhD – Pfizer
    Speaker: Eric Masson, PharmD – Arvinas
    Preconference
  • Sunday, Nov 10th
    1:45 PM – 2:10 PM MST
    Applications of A Platform PBPK Model of Antisense Oligonucleotides Towards Candidate Selection, Tox Study Design and Human Dose Projection
    Location: Sonoran Sky Ballroom 4
    Preconference
  • Sunday, Nov 10th
    2:10 PM – 2:35 PM MST
    Model-Informed Drug Development Applications to Oncology Bispecifics and Antibody-Drug Conjugates
    Location: Sonoran Sky Ballroom 4
    Speaker: Donghua Yin, PhD – Pfizer
    Preconference
  • Sunday, Nov 10th
    2:35 PM – 3:00 PM MST
    Unique Model Informed Drug Development Opportunities with PROTAC Protein Degrader
    Location: Sonoran Sky Ballroom 4
    Speaker: Eric Masson, PharmD – Arvinas
    Preconference
  • Sunday, Nov 10th
    3:15 PM – 4:30 PM MST
    Interactive Session: Development Challenges for New Therapeutic Modalities
    Location: Sonoran Sky Ballroom 4
    Facilitator: Peter Bonate, PhD – Executive Director at Astellas/ Editor-in-Chief, JPKPD
    Preconference
  • Sunday, Nov 10th
    4:30 PM – 4:45 PM MST
    Preconference Concluding Remarks
    Location: Sonoran Sky Ballroom 4
    Speaker: Joy C. Hsu, PhD – Genentech
    Speaker: Mark Lovern, PhD (he/him/his) – InSilicoTrials
    Preconference